Millendo Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome March 19, 2019
ArcherDX Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth March 5, 2019
KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting February 25, 2019
